![Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers](https://www.mdpi.com/cancers/cancers-13-05081/article_deploy/html/images/cancers-13-05081-g001.png)
Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
![Pharmaceutics | Free Full-Text | The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers Pharmaceutics | Free Full-Text | The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-15-01686/article_deploy/html/images/pharmaceutics-15-01686-g001.png?1686272801)
Pharmaceutics | Free Full-Text | The Nanotechnology-Based Approaches against Kirsten Rat Sarcoma-Mutated Cancers
![Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations | Journal of Clinical Oncology Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.20.00744/asset/images/large/jco.20.00744t3.jpeg)
Targeting KRAS-Mutant Non–Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations | Journal of Clinical Oncology
![Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling | Circulation Research Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling | Circulation Research](https://www.ahajournals.org/cms/asset/184edb61-bbed-47cd-a6b4-0a60fc5e1e99/circresaha.119.316500.fig08.jpg)
Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling | Circulation Research
![Frontiers | Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer Frontiers | Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer](https://www.frontiersin.org/files/Articles/1055019/fonc-12-1055019-HTML/image_m/fonc-12-1055019-g001.jpg)
Frontiers | Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
![Cancers | Free Full-Text | Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner Cancers | Free Full-Text | Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner](https://pub.mdpi-res.com/cancers/cancers-14-01628/article_deploy/html/images/cancers-14-01628-g001.png?1648085245)
Cancers | Free Full-Text | Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
![Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions](https://www.mdpi.com/cells/cells-12-00749/article_deploy/html/images/cells-12-00749-g001.png)
Cells | Free Full-Text | KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions
![KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram](https://www.researchgate.net/publication/51761761/figure/fig1/AS:393900016586757@1470924490835/Fig-1-KRAS-testing-is-a-screening-of-non-responders-to-anti-EGFR-therapy.png)
KRAS testing is a screening of non-responders to anti-EGFR therapy.... | Download Scientific Diagram
![Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma | npj Precision Oncology Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-024-00505-0/MediaObjects/41698_2024_505_Fig1_HTML.png)
Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma | npj Precision Oncology
![Identification of KRASG12C Mutations in Circulating Tumor DNA in Patients With Cancer | JCO Precision Oncology Identification of KRASG12C Mutations in Circulating Tumor DNA in Patients With Cancer | JCO Precision Oncology](https://ascopubs.org/cms/10.1200/PO.21.00547/asset/images/large/po.21.00547t1.jpeg)
Identification of KRASG12C Mutations in Circulating Tumor DNA in Patients With Cancer | JCO Precision Oncology
![Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12943-022-01629-2/MediaObjects/12943_2022_1629_Fig1_HTML.png)
Targeting KRAS mutant cancers: from druggable therapy to drug resistance | Molecular Cancer | Full Text
![KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond - ScienceDirect KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0305737221001572-gr1.jpg)
KRAS Inhibitors– yes but what next? Direct targeting of KRAS– vaccines, adoptive T cell therapy and beyond - ScienceDirect
![Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers](https://www.mdpi.com/cancers/cancers-13-05081/article_deploy/html/images/cancers-13-05081-g003.png)
Cancers | Free Full-Text | Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers
![PDF] Current Advances and Trends in KRAS Targeted Therapies for Colorectal Cancer | Semantic Scholar PDF] Current Advances and Trends in KRAS Targeted Therapies for Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1cb809042417b8f137ee1ff827a6e5cd9aed30d5/3-Table1-1.png)